Strategies for the control of pneumococcal diseases

Vaccine

Volumn 17, Issue SUPPL. 1, 1999, Pages

  Mulholland, Kim ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antimicrobial resistance; Developing countries; Disease burden; Pneumonia; Streptococcus pneumoniae; Vaccines

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HIGH RISK POPULATION; HOST RESISTANCE; HUMAN; INFECTION PREVENTION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PENICILLIN RESISTANCE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACTERIAL VACCINES; HUMANS; PNEUMOCOCCAL INFECTIONS;

EID: 0033618360     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00112-7     Document Type: Conference Paper

References (41)

1. Johnston RB. Pathogenesis of pneumococcal pneumonia. Rev Infect Dis 1991;13(Suppl 6):S509-517.
2. Gove S. Integrated management of childhood illness by outpatient health workers: technical basis and overview. Bull WHO 1997;75(Suppl 1):7-24.
3. World Development Report 1993 1993 Washington: The World Bank.
4. Obaro SK, Monteil MA, Henderson DC. The pneumococcal problem. BMJ 1996;312:1521-5.
5. Fedson D. Pneumococcal vaccine. In: Plotkin SA, Orenstein W, editors. Vaccines, 3rd ed. Philadelphia: W.B. Saunders, 1998.
6. The WHO Young Infants Study Group, The etiology of serious bacterial infection in young infants in four developing countries, Pediatr Infect Dis J (in press);.
7. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
8. Casadevall A, Scharff MD. Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother 1994;38:1695-702.
9. Hendrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995;33:2759-62.
10. Nahm MH, Ward J, Chang S et al. 1997 Young children may produce antibodies against Streptococcus pneumonia that are reactive but not opsonophagocytic to cross-reactive serotypes. Abstract G-82, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto.
11. Torzillo P, Hanna J, Morey F, et al. Invasive pneumococcal disease in central Australia. Med J Aust 1995;162:182-6.
12. Davidson M, Parkinson AJ, Bulkow LR, et al. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 -ethnic differences and opportunities for prevention. J Infect Dis 1994; 170:368-76.
13. Zangwill KM, Vadheim CM, Vannier CM, et al. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis 1996;174:752-9.
14. Usen S, Adegbola R, Mulholland K, et al. Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia. Pediatr Infect Dis J 1998;17:23-8.
15. O'Dempsey TJD, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease among children in a rural area of West Africa. Pediatr Infect Dis J 1996;15:431-7.
16. Falade AG, Mulholland EK, Adegbola RA, Greenwood BM. Bacterial isolates from blood and lung aspirate cultures in Gambian children with lobar pneumonia. Ann Trop Paediatr 1997;17:315-9.
17. Leowski J. Mortality from acute respiratory infections in children under 5 years of age: global estimates. World Health Stat Quart 1986;39:138-44.
18. Adegbola RA, Falade AG, Baldeh I, Greenwood BM, Mulholland EK. The aetiology of pneumonia in malnourished and well nourished Gambian children. Pediatr Infect Dis J 1994;13:975-82.
19. Murray CJL, Lopez AD. Global Health Statistics. Boston: Harvard School of Public Health, 1996.
20. Ostroff SM, Harrison LH, Khallaf N, et al. Resistance patterns of Streptococcus pneumoniae and Haemophilus influenzae isolates recovered in Egypt from children with pneumonia. Clin Infect Dis 1996;23:1069-74.
21. Bogaerts J, Lepage P, Taelman H, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990. J Infect 1993;27:157-68.
22. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(Suppl C):31-8.
23. Appelbaum P. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
24. Brandileone MCdeC, Viera VSD, Casagrande ST, et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Microb Drug Resist 1997;3:141-6.
25. Nuttall N, Lyon D, Faoagali J et al. 1997 Penicillin resistant Streptococcus pneumoniae: a 1996 comparison of two western Pacific hospitals. Abstract 2086, 20th International Congress of Chemotherapy, Sydney.
26. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992;15:119-27.
27. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
28. Butler JC, Brieman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826-31.
29. Ortqvist A, Hedlund J, Burman L, et al. Randomized trial of 23 valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 1998;351:399-403.
30. Riley ID, Lehmann D, Alpers MP, et al. Pneumococcal vaccine prevents death from acute lower respiratory tract infections in Papua New Guinean children. Lancet 1986;2:877-81.
31. Lehmann D, Marshall TFdeC, Riley ID, Alpers MD. Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children. Ann Trop Paediatr 1991;11:247-57.
32. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Pediatr 1991;164:982-6.
33. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993;122:517-23.
34. Mbelle N, Wasas A, Huebner R et al. 1997 Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to South African infants. Abstract LB-21, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto.
35. Kristinsson KG, Sigurdardottir ST, Gudnason T et al. 1997 Effect of vaccination with octavalent protein conjugated pneumococcal vaccines on pneumococcal carriage in infants. Abstract G-5, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto.
36. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8.
37. Obaro SK, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996;348:271-2.
38. O'Brien KL, Steinhoff MC, Edwards K, et al. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines. Pediatr Infect Dis J 1996;15:425-30.
39. Block SL, Hedrick JA, Smith RA et al. 1997 Pneumococcal conjugate vaccine (PCV) vs pneumococcal polysaccharide vaccine 23 in 6 month old infants after 2 prior doses of PCV. Abstract G-88, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto.
40. Yamamoto M, McDaniel LS, Kawabata K, et al. Oral immunization with PspA elicits protective humoral immunity against streptococcus pneumoniae infection. Infect Immun 1997;65:640-4.
41. Briles DE, King JD, Gray MA, et al. PspA, a protection eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 1996;14:858-67.